10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2012 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Net revenues | $ 123,133 | 107,100 | 95,778 |
| Cost of revenues | 100,627 | 86,539 | 75,559 |
| Gross profit | 22,506 | 20,561 | 20,219 |
| Operating expenses | 15,278 | 14,231 | 14,082 |
| Operating profit | 7,228 | 6,330 | 6,137 |
| Interest expense, net | 557 | 584 | 536 |
| Loss on early extinguishment of debt | 348 | ||
| Income before income tax provision | 6,323 | 5,746 | 5,601 |
| Income tax provision | 2,441 | 2,258 | 2,179 |
| Income from continuing operations | 3,882 | 3,488 | 3,422 |
| Income (loss) from discontinued operations, net of tax | (7) | (31) | 2 |
| Net income | 3,875 | 3,457 | 3,424 |
| Net loss attributable to noncontrolling interest | 2 | 4 | 3 |
| Net income attributable to CVS Caremark | 3,877 | 3,461 | 3,427 |
| Basic earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.06 | 2.61 | |
| Income (loss) from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.01) | (0.02) | |
| Net income attributable to CVS Caremark (in dollars per share) | 3.05 | 2.59 | |
| Weighted average common shares outstanding (in shares) | 1,271 | 1,338 | 1,367 |
| Diluted earnings per common share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.03 | 2.59 | |
| Income (loss) from discontinued operations attributable to CVS Caremark (in dollars per share) | (0.01) | (0.02) | |
| Net income attributable to CVS Caremark (in dollars per share) | 3.03 | 2.57 | |
| Weighted average common shares outstanding (in shares) | 1,280 | 1,347 | 1,377 |
| Dividends declared per common share | 0.65 | 0.50 | |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2012 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Net income | $ 3,875 | 3,457 | 3,424 |
| Other comprehensive income (loss): | |||
| Net cash flow hedges, net of income tax | 3 | (9) | (1) |
| Pension liability adjustment, net of income tax | (12) | (20) | (7) |
| Comprehensive income | 3,866 | 3,428 | 3,416 |
| Comprehensive loss attributable to noncontrolling interest | 2 | 4 | 3 |
| Comprehensive income attributable to CVS Caremark | 3,868 | 3,432 | 3,419 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2012 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 113,205 | 97,688 | 94,503 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (90,032) | (75,148) | (73,143) |
| Cash paid to other suppliers and employees | (13,643) | (13,635) | (13,778) |
| Interest received | 4 | 4 | 4 |
| Interest paid | (581) | (647) | (583) |
| Income taxes paid | (2,282) | (2,406) | (2,224) |
| Net cash provided by operating activities | 6,671 | 5,856 | 4,779 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,030) | (1,872) | (2,005) |
| Proceeds from sale-leaseback transactions | 529 | 592 | 507 |
| Proceeds from sale of property and equipment | 23 | 4 | 34 |
| Acquisitions (net of cash acquired) and other investments | (378) | (1,441) | (177) |
| Purchase of available-for-sale investments | (3) | ||
| Maturity of available-for-sale investments | 60 | 1 | |
| Proceeds from sale of subsidiary | 7 | 250 | |
| Net cash used in investing activities | (1,849) | (2,410) | (1,640) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (60) | 450 | (15) |
| Proceeds from issuance of long-term debt | 1,239 | 1,463 | 991 |
| Repayments of long-term debt | (1,718) | (2,122) | (2,103) |
| Purchase of noncontrolling interest in subsidiary | (26) | ||
| Dividends paid | (829) | (674) | (479) |
| Derivative settlements | (19) | (5) | |
| Proceeds from exercise of stock options | 836 | 431 | 285 |
| Excess tax benefits from stock-based compensation | 28 | 21 | 28 |
| Repurchase of common stock | (4,330) | (3,001) | (1,500) |
| Other | (9) | ||
| Net cash used in financing activities | (4,860) | (3,460) | (2,798) |
| Net increase (decrease) in cash and cash equivalents | (38) | (14) | 341 |
| Cash and cash equivalents at the beginning of the year | 1,413 | 1,427 | |
| Cash and cash equivalents at the end of the year | 1,375 | 1,413 | 1,427 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,875 | 3,457 | 3,424 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,753 | 1,568 | 1,469 |
| Stock-based compensation | 132 | 135 | 150 |
| Loss on early extinguishment of debt | 348 | ||
| Gain on sale of subsidiary | (53) | ||
| Deferred income taxes and other noncash items | (106) | 144 | 30 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (387) | (748) | 532 |
| Inventories | (858) | 607 | (352) |
| Other current assets | 3 | (420) | (4) |
| Other assets | (99) | (49) | (210) |
| Accounts payable and claims and discounts payable | 1,147 | 1,128 | (40) |
| Accrued expenses | 753 | 85 | (176) |
| Other long-term liabilities | 110 | 2 | (44) |
| Net cash provided by operating activities | 6,671 | 5,856 | 4,779 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2012 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| Assets: | ||
| Cash and cash equivalents | $ 1,375 | 1,413 |
| Short-term investments | 5 | 5 |
| Accounts receivable, net | 6,473 | 6,047 |
| Inventories | 10,759 | 10,046 |
| Deferred income taxes | 663 | 503 |
| Other current assets | 577 | 580 |
| Total current assets | 19,852 | 18,594 |
| Property and equipment, net | 8,632 | 8,467 |
| Goodwill | 26,395 | 26,458 |
| Intangible assets, net | 9,753 | 9,869 |
| Other assets | 1,280 | 1,155 |
| Total assets | 65,912 | 64,543 |
| Liabilities: | ||
| Accounts payable | 5,070 | 4,370 |
| Claims and discounts payable | 3,974 | 3,487 |
| Accrued expenses | 4,051 | 3,293 |
| Short-term debt | 690 | 750 |
| Current portion of long-term debt | 5 | 56 |
| Total current liabilities | 13,790 | 11,956 |
| Long-term debt | 9,133 | 9,208 |
| Deferred income taxes | 3,784 | 3,853 |
| Other long-term liabilities | 1,501 | 1,445 |
| Commitments and contingencies (Note 13) | ||
| Redeemable noncontrolling interest | 30 | |
| Shareholders' equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,667 shares issued and 1,231 shares outstanding at December 31, 2012 and 1,640 shares issued and 1,298 shares outstanding at December 31, 2011 | 17 | 16 |
| Treasury stock, at cost: 435 shares at December 31, 2012 and 340 shares at December 31, 2011 | (16,270) | (11,953) |
| Shares held in trust: 1 share at December 31, 2012 and 2 shares at December 31, 2011 | (31) | (56) |
| Capital surplus | 29,120 | 28,126 |
| Retained earnings | 25,049 | 22,090 |
| Accumulated other comprehensive loss | (181) | (172) |
| Total shareholders' equity | 37,704 | 38,051 |
| Total liabilities and shareholders' equity | 65,912 | 64,543 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |